Marcadia Biotech is a biotechnology company founded in 2005 with a focus on developing life-enhancing therapeutic products for diabetes and obesity. The company harnesses proprietary peptide chemistry to create solutions aimed at significantly improving the quality of life for individuals affected by these conditions. Marcadia Biotech's robust collection of compounds in various stages of research and development underscores its commitment to innovation and addressing unmet medical needs within the biotechnology and health care industries.
The company's recent milestone includes a $15.00M Series A investment secured on 15 May 2007, with participation from 5AM Ventures, Frazier Healthcare Partners, and Twilight Venture Partners. This injection of capital bolsters Marcadia Biotech's pursuit of advancing its therapeutic solutions and driving forward its efforts to address and mitigate the complications associated with diabetes and obesity.
